Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
263.04
+1.27 (+0.49%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,120,224
Open
260.00
Bid (Size)
262.00 (100)
Ask (Size)
263.10 (1,000)
Prev. Close
261.77
Today's Range
257.80 - 264.81
52wk Range
190.75 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.63%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Dividend Stocks That Are No-Brainer Buys Right Now, Starting With This Healthcare Giant
↗
Today 12:35 EDT
These three stocks meet multiple criteria for long-term dividend investing success.
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline
↗
Today 12:02 EDT
AbbVie (NYSE:ABBV) executives outlined a pipeline and business-development strategy centered on immunology, neuroscience, oncology and obesity, while highlighting plans to expand beyond the company’s...
Via
MarketBeat
Topics
ETFs
Performance
YTD
+14.7%
+14.7%
1 Month
+5.1%
+5.1%
3 Month
+18.2%
+18.2%
6 Month
+19.7%
+19.7%
1 Year
+20.9%
+20.9%
More News
Read More
Billionaire Ken Griffin Just Loaded Up on This Dividend King, and Wall Street Still Sees Upside
↗
September 14, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 14, 2026
Via
The Motley Fool
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock?
↗
September 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 10, 2026
Via
The Motley Fool
Topics
Intellectual Property
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
↗
September 09, 2026
Via
Benzinga
AbbVie Highlights SKYRIZI, RINVOQ Growth and Pipeline Catalysts at Wells Fargo Conference
↗
September 09, 2026
Via
MarketBeat
2 Dividend Stocks Built to Hold Up When Markets Don't
↗
September 09, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Billionaire Israel Englander Is Doubling Down on These 2 Outstanding Dividend Stocks. Should You?
↗
September 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
If I Were in My 20s, I'd Buy This Vanguard ETF Warren Buffett Recommended and Hold It Forever
↗
September 08, 2026
Via
The Motley Fool
Topics
ETFs
Economy
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now
↗
September 08, 2026
Via
The Motley Fool
Topics
Intellectual Property
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It
↗
September 06, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Bonds
3 Dividend Stocks to Buy and Hold Forever (Including 1 Dividend King)
↗
September 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
↗
September 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
True Beauty Aesthetics Marks One-Year Milestone With Open House
September 02, 2026
Via
Press Advantage
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 29, 2026
Via
The Motley Fool
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 29, 2026
Via
The Motley Fool
If You Invested $100 In AbbVie Stock 10 Years Ago, You Would Have This Much Today
↗
August 26, 2026
Via
Benzinga
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.
↗
August 26, 2026
Via
The Motley Fool
2 S&P 500 Stocks with Exciting Potential and 1 We Brush Off
August 25, 2026
Via
StockStory
Topics
Electric Vehicles
Stocks
World Trade
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
↗
August 24, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Dividend Stocks to Buy and Never Sell
↗
August 23, 2026
Via
The Motley Fool
Topics
Economy
The Dividend ETF That Generates Passive Income While You Sleep
↗
August 21, 2026
Via
The Motley Fool
Topics
ETFs
3 Unpopular Stocks That Deserve Some Love
August 21, 2026
Via
StockStory
Topics
Energy
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 263.04
When was AbbVie last traded?
The last trade of AbbVie was at 09/15/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.